This case is about Fuzeon, an innovative ‘first of its kind’ drug used for the treatment of HIV/AIDS. The drug was developed by Trimeris and marketed by Roche. Though Fuzeon was considered a ‘breakthrough’ drug, its price was very high. The case discusses the reasons as to why the company had decided to price the drug at a premium.
Fuzeon’s pricing also raised ethical concerns as it was priced out of the reach of people who needed it the most. The case also discusses the challenges faced by Trimeris and Roche in marketing this drug. Click here to read more…
- Powered by Article Dashboard drug rehab canada
- powered by myBB drug rehab center
- powered by SMF people from
- powered by myBB california drug rehab
- Powered by Article Dashboard drug rehabilitation centres
- powered by myBB the center
- powered by SMF people in the u s
- powered by myBB medical drug information
- Powered by Article Dashboard drug rehabilitation treatment
- powered by SMF california business for sale
Related Case Studies:
- Case Study on the Use of Cost-Plus Pricing In the business world of economic manufacturing and production, there...
- Case Study on Cost Reduction Vytra reduced its call center costs by over $500,000 (+16%)...
- Cost Accounting a Network – A Case Study This paper presents a case study of how Dartmouth College...
- Case Study in Sony Cost Cutting Strategies Since its inception in 1946, Sony Corporation has been known...
- Six Sigma Case Study Cost Reduction Through Capability This Six Sigma case study looks at how product cost...